GlobalData on MSN2d
Junshi partners LEO Pharma for toripalimab distribution in Europe
LEO Pharma thrombosis business unit executive vice-president Jean Monin stated: “We are excited to partner with Junshi Biosciences, supplementing LEO Pharma’s Thrombosis busin ...
FiercePharma2d
Leo bags EU rights to Junshi's Loqtorzi, putting marketing muscle behind PD-1 launch
Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...
Investigating Magistrate Appointed in Belgium in Congo Conflict Minerals Case
(Reuters) - An investigating magistrate has been appointed in Belgium after Democratic Republic of the Congo in December ...
emjreviews.com3d
LEO Pharma to market Junshi Biosciences’s toripalimab
Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of multiple malignant tumors. To date, toripalimab has been approved for marketing ...